Greenphire partners with Lazarex to ease oncology trial reimbursement

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Alexialex)
(Image: Getty/Alexialex)

Related tags: Greenphire, Clinical trial, Oncology, trial recruitment, Patient centricity, Patient access, Patient recruitment

Lazarex partners with Greenphire to implement the latter’s ClinCard reimbursement technology to improve patient participation in oncology trials.

According to the financial software for clinical trials company, Greenphire, oncology trials are difficult to recruit participants for as travel and location present key obstacles. The company added that studies show that 6% of adult cancer patients enroll in a clinical trial due to the lack of financial resources.

A spokesperson for Greenphire told us that 56% of patients cited travel as a prominent reason for not participating in a clinical trial, as their institution didn’t have a trial available. The spokesperson added that financial assistance can provide access to treatment by enabling patients to travel to trial sites.

Lazarex Cancer Foundation reimburses travel expenses which can be a significant financial burden for patients facing a life-threatening illness as well as assists in connecting patients to trials.

Through this partnership, Lazarex will use Greenphire’s ClinCard, a reloadable debit card​, with no upfront costs required by the patients. The ClinCard, according to Greenphire, will enable instantaneous payment for travel to a research facility including any out-of-pocket expenses such as flights, lodging gas, parking and tolls.

ClinCard has been used in more than six million reimbursements to over one million clinical trial participants worldwide. The card can transfer funds from sponsors and contract research organization (CROs) to sites and patients. 

Through the partnership, Lazarex said it will expand the amount of patients it can assist from 600 to 1,000 patients per month.

Dana Dornsife, president of Lazarex said in a statement that the organization has reimbursed patients out of pocket for 12 years through a paper checks and receipts.

She added that this has been a “very labor intensive”​ process and that through a partnership with Greenphire the organization can increase its bandwidth by having funds implemented immediately on ClinCard.

Greenphire has lent a hand in removing travel barriers in clinical trials previously as it began to work with Lyft​ earlier this year to provide ease of travel and reimbursement to study participants.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars